HIV Vaccine Science Academy

2024 HIV Vaccine Science Academy

Tue, 7 May 2024

7:00am - 6:00pm [CEST]

The HIV Vaccine Science Academy aims at supporting early- and mid-career investigators conducting HIV vaccine research in Africa by providing opportunities for training, networking and mentorship. The Academy is designed to support the participants in establishing themselves as independent researchers and team leaders in their respective host institutions, thus contributing to long-term continuity, networking and research ownership in central, eastern, southern and western Africa in the effort to develop a safe and effective HIV vaccine.

The HIV Vaccine Science Academy offers: 

  • Training on state-of-the-art HIV vaccine research and development, notably vaccine design, trial design, laboratory and data analysis and training in the use of relevant scientific tools and skills (e.g. scientific writing). 
  • Opportunities for the participants to engage and discuss with leaders in the HIV vaccine field, in a retreat-type setting, with a view to build and facilitate collaborations in the search for an HIV vaccine. 
  • A platform for the participants to establish a sustainable network across different research institutions and contribute to African-led research. 

The HIV Vaccine Science Academy will welcome 15 fellows and be held in person over three days. 

The academy will serve as a space where participants can interact with leading researchers and experts in the HIV vaccine R&D field. The comprehensive programme will be led by renowned scientists, including vaccine researchers, social scientists, and ethicists. It will use a participative approach to deliver interactive classroom sessions on key topics related to HIV vaccine research and development.

Morning sessions will be devoted to science plenaries led by leading researchers. Afternoons will be dedicated to interactive group discussions focused on specific skill building workshops. Participants will be able to informally interact with researchers and advocates throughout lectures, workshops and networking sessions.

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.